Results 141 to 150 of about 1,253,356 (303)

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad, Taimoon Rasheed, Momina Riaz Siddiqui, Hamza Hamid, Marwah Bintay Khalid, Haroon Shabbir, Besher Shami, Abdullah, Syed Ijlal Ahmed   +8 more
wiley   +1 more source

Preparedness and Response Considerations for High-Consequence Infectious Disease. [PDF]

Emerg Infect Dis
Chan J, Levine CB, Herstein JJ, Cloutier N, Sauer L, Mehta AK, Evans J, Basic and Translational State of the Science Working Group of the National Emerging Special Pathogens Training and Education Center’s Special Pathogens Research Network.   +7 more
europepmc   +1 more source

Epidemiology and Laboratory Diagnosis of Infectious Jaundice (Weil's Disease)

, 1941
Joseph G. Molner, Joseph A. Kasper
openalex   +2 more sources

CARRIERS IN INFECTIOUS DISEASES.1 [PDF]

, 1923

openalex   +1 more source

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock, Jihyun Park, Dae‐Gyu Jang, Bangyao Zhao, Samuel J. Teener, Ian F. Webber‐Davis, Lili Zhao, Eva L. Feldman, Stephen A. Goutman   +8 more
wiley   +1 more source

Surveillance System for Infectious Disease Prevention and Management: Direction of Korea's Infectious Disease Surveillance System. [PDF]

J Korean Med Sci
Jang Y, Lee H, Park H.
europepmc   +1 more source

Nanomedicine for Infectious Diseases [PDF]

Nanomedicine, 2020
Harald Unterweger, Stefan Lyer, Christina Janko, Ralf P Friedrich, Iwona Cicha, Rainer Tietze, Christoph Alexiou   +6 more
openaire   +3 more sources

Association of the ICH Score With Withdrawal of Life‐Sustaining Treatment Over a 10‐Year Period

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The intracerebral hemorrhage (ICH) score was developed to enhance provider communication and facilitate early severity assessment. We examined the association of the ICH score with mortality and withdrawal of life‐sustaining treatment (WLST) in a large, multicenter stroke registry, and evaluated temporal trends in these associations.
Nina Massad, Lili Zhou, Brian Manolovitz, Negar Asdaghi, Hannah Gardener, Hao Ying, Carolina M. Gutierrez, Angus Jameson, David Rose, Mohan Kottapally, Amedeo Merenda, Kristine O'Phelan, Sebastian Koch, Jose G. Romano, Tatjana Rundek, Ayham Alkhachroum   +15 more
wiley   +1 more source

Comparative Effect of Standard Versus Extended Interval Dosing of Rituximab or Ocrelizumab in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aimed to investigate the comparative effectiveness of standard versus personalized extended interval dosing of anti‐CD20 therapy on clinical and sub‐clinical outcomes in multiple sclerosis. Methods Clinical information was collected prospectively on Research Electronic Data Capture.
Nabil K. El Ayoubi, Fares Fahd, Hani Tamim, Salem Hannoun, Mark Bal, Elham El‐Hallak, Samia J. Khoury   +6 more
wiley   +1 more source

Synthetic method of analogues for emerging infectious disease forecasting. [PDF]

PLoS Comput Biol
Murph AC, Gibson GC, Amona EB, Beesley LJ, Castro LA, Del Valle SY, Osthus D.   +6 more
europepmc   +1 more source